This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 ETF Strategies to Follow Warren Buffett's Coronavirus Tips
by Sanghamitra Saha
Warren Buffett's Berkshire Hathaway's shareholder meeting divulges his outlook on COVID-19. Follow him with these ETF strategies.
Zacks Earnings Trends Highlights: Ford, Delta Air, Starbucks, Boeing, Alphabet, Coca-Cola and Proctor & Gamble
by Zacks Equity Research
Zacks Earnings Trends Highlights: Ford, Delta Air, Starbucks, Boeing, Alphabet, Coca-Cola and Proctor & Gamble
The Coronavirus Pandemic and its Impact on Corporate Earnings
by Sheraz Mian
For the 193 S&P 500 members that have reported Q1 results, total earnings or aggregate net income is down -17.1% on +0.6% higher revenues...
The Coronavirus Pandemic and its Impact on Corporate Earnings
by Sheraz Mian
For the 193 S&P 500 members that have reported Q1 results, total earnings or aggregate net income is down -17.1% on +0.6% higher revenues...
Zacks Earnings Trends Highlights: AT&T, Kimberly-Clark, Coca-Cola and Proctor & Gamble
by Zacks Equity Research
Zacks Earnings Trends Highlights: AT&T, Kimberly-Clark, Coca-Cola and Proctor & Gamble
Making Sense of the Earnings Picture During the Coronavirus
by Sheraz Mian
The ongoing Q1 earnings season is less about what happened in the January-through-March period and more about evolving expectations for the current and coming quarters, which continue to be set lower as a result of the pandemic...
Making Sense of the Earnings Picture During the Coronavirus
by Sheraz Mian
The ongoing Q1 earnings season is less about what happened in the January-through-March period and more about evolving expectations for the current and coming quarters, which continue to be set lower as a result of the pandemic...
Staples ETFs to Gain from Upbeat PG Earnings & Dividend Hike
by Sanghamitra Saha
Procter & Gamble reported mixed earnings, solid U.S. sales, decent outlook and also hiked dividend. This should propel staples ETFs ahead.
Company News for Apr 20, 2020
by Zacks Equity Research
Companies In The News Are: TROX, MRNA, PLNT and PG
Procter & Gamble (PG) Q3 Earnings Beat Estimates, Sales Up
by Zacks Equity Research
Procter & Gamble's (PG) bottom line beats estimates in third-quarter fiscal 2020, while sales meet the same. Free cash flow productivity increases to 113%.
Procter & Gamble (PG) Tops Q3 Earnings Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 4.46% and 0.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Coronavirus Ruins March Retail Sales: Top & Flop ETF Areas
by Sanghamitra Saha
March retail sales saw a record decline due to the coronavirus-led economic shutdown. These ETF areas won/lost in the month.
What's in Store for Dow ETFs in Q1 Earnings?
by Sweta Killa
With most blue-chip companies' earnings scheduled over the coming weeks, investors should closely monitor the movement of the Dow ETF.
Coronavirus Crisis Brings These 4 ESG Stocks in Focus
by Zacks Equity Research
Companies focused on environmental, social and governance factors are showing substantial resistance during the coronavirus-led downturn. Here are four stocks to keep a watch on.
Procter & Gamble Rewards Investors Amid Coronavirus Despair
by Zacks Equity Research
Although U.S. companies are reeling under the uncertain impacts of the coronavirus, Procter & Gamble's (PG) recent move to hike dividend comes as a sigh of relief for investors.
Factors Setting Tone for Procter & Gamble's (PG) Q3 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) third-quarter fiscal 2020 results are expected to reflect gains from continued operations of its facilities despite the coronavirus outbreak.
Procter & Gamble (PG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
P&G (PG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Highly-Ranked Stocks to Buy for the Coronavirus Economy & the Eventual Recovery
by Benjamin Rains
On today's episode of Full Court Finance, we explore three stocks that appear to be buys at the moment and down the road when the economy eventually turns around from the coronavirus downturn...
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $114.52 in the latest trading session, marking a -0.5% move from the prior day.
Why the Earnings Surprise Streak Could Continue for P&G (PG)
by Zacks Equity Research
P&G (PG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Procter & Gamble, AbbVie, QUALCOMM, PepsiCo and CME Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, AbbVie, QUALCOMM, PepsiCo and CME Group
Top Analyst Reports for Procter & Gamble, AbbVie & QUALCOMM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), AbbVie (ABBV) and QUALCOMM (QCOM).
Why Procter & Gamble (PG) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Procter & Gamble (PG) have what it takes? Let's find out.
Procter & Gamble (PG) Stock Moves -0.58%: What You Should Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $109.36, marking a -0.58% move from the previous day.
Why Clorox (CLX) Stock is a Long-Term Buy Far Beyond the Coronavirus
by Benjamin Rains
Clorox sells disinfectant products that kill germs at home and in healthcare settings, which makes it almost tailor-made for the coronavirus economy. Better still, Clorox's portfolio is far more diverse and CLX appears to be a solid longer-term buy...